Works matching DE "CYTOKINE release syndrome"
Results: 2489
BiTE immuno-oncology therapy appears safe with preliminary efficacy in mCRPC: More than 25% of patients show confirmed PSA response to investigational treatment.
- Published in:
- Urology Times, 2020, v. 48, n. 11, p. 25
- By:
- Publication type:
- Article
Pro‐Peptide‐Reinforced, Mucus‐Penetrating Pulmonary siRNA Delivery Mitigates Cytokine Storm in Pneumonia.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 21, p. 1, doi. 10.1002/adfm.202008960
- By:
- Publication type:
- Article
Cytokine Storm Biomarkers: A Flexible and Regenerative Aptameric Graphene–Nafion Biosensor for Cytokine Storm Biomarker Monitoring in Undiluted Biofluids toward Wearable Applications (Adv. Funct. Mater. 4/2021).
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 4, p. 1, doi. 10.1002/adfm.202170026
- By:
- Publication type:
- Article
A Flexible and Regenerative Aptameric Graphene–Nafion Biosensor for Cytokine Storm Biomarker Monitoring in Undiluted Biofluids toward Wearable Applications.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 4, p. 1, doi. 10.1002/adfm.202005958
- By:
- Publication type:
- Article
Ferritin Nanocage‐Based Methyltransferase SETD6 for COVID‐19 Therapy.
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 48, p. 1, doi. 10.1002/adfm.202006110
- By:
- Publication type:
- Article
Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
- Published in:
- Cancer & Metastasis Reviews, 2020, v. 39, n. 2, p. 337, doi. 10.1007/s10555-020-09889-4
- By:
- Publication type:
- Article
Efficacy of rituximab in patients with Graves' orbitopathy: a retrospective multicenter nationwide study.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2020, v. 258, n. 9, p. 2013, doi. 10.1007/s00417-020-04651-6
- By:
- Publication type:
- Article
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 8, p. 1225, doi. 10.1007/s00228-021-03106-z
- By:
- Publication type:
- Article
Pharmacotherapy of Cytokine Release Syndrome in Severe COVID-19 Patients: A Systematic Review.
- Published in:
- Global Journal of Medical Pharmaceutical & Biomedical Update, 2021, v. 16, p. 1, doi. 10.25259/GJMPBU_9_2021
- By:
- Publication type:
- Article
Oncolytic Virotherapy and The Immune System.
- Published in:
- International Journal of High School Research, 2023, v. 5, n. 4, p. 28, doi. 10.36838/v5i4.5
- By:
- Publication type:
- Article
Łysienie telogenowe jako przejaw zakażenia SARS-CoV-2.
- Published in:
- Forum Dermatologicum, 2023, v. 9, n. 1, p. 32, doi. 10.5603/FD.a2022.0025
- By:
- Publication type:
- Article
Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects.
- Published in:
- Cell Transplantation, 2024, v. 33, p. 1, doi. 10.1177/09636897241247951
- By:
- Publication type:
- Article
Withania Somnifera Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia Effect.
- Published in:
- Cell Transplantation, 2024, v. 33, p. 1, doi. 10.1177/09636897241226573
- By:
- Publication type:
- Article
Outcomes of Second Anti-CD19 CAR T-Cell Therapy (CART2) in Acute B Lymphoblastic Leukemia and the Impact of Allo-HSCT on Efficacy.
- Published in:
- Cell Transplantation, 2023, v. 32, p. 1, doi. 10.1177/09636897231204724
- By:
- Publication type:
- Article
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma.
- Published in:
- Cell Transplantation, 2023, v. 32, p. 1, doi. 10.1177/09636897231194265
- By:
- Publication type:
- Article
Cytokine Release Syndrome After Modified CAR-NK Therapy in an Advanced Non-small Cell Lung Cancer Patient: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Relation between severity of re-infection and vaccination with first and second dose Covied-19 virus.
- Published in:
- Karbala Journal of Pharmaceutical Sciences, 2023, v. 1, n. 21, p. 108
- By:
- Publication type:
- Article
Cytokine storm in covid-19.
- Published in:
- Karbala Journal of Pharmaceutical Sciences, 2022, v. 1, n. 20, p. 16
- By:
- Publication type:
- Article
Role of IL6 Antagonist, Tocilizumab in Treating Covid 19; A Narrative Review.
- Published in:
- Kerbala Jorunal of Medicine, 2020, v. 13, n. 2, p. 2384
- By:
- Publication type:
- Article
Persistent musculoskeletal symptoms in Acute Post-COVID-19 Syndrome: an integrative review.
- Published in:
- Brazilian Journal of Occupational Therapy / Cadernos Brasileiros de Terapia Ocupacional, 2024, v. 32, p. 1, doi. 10.1590/2526-8910.ctoAR392938042
- By:
- Publication type:
- Article
Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, p. 3391, doi. 10.3906/sag-2110-179
- By:
- Publication type:
- Article
Tocilizumab and COVID-19: a meta-analysis of 2120 patients with severe disease and implications for clinical trial methodologies.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 3, p. 890, doi. 10.3906/sag-2010-131
- By:
- Publication type:
- Article
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs.
- Published in:
- Turkish Journal of Medical Sciences, 2020, v. 50, n. SI, p. 620, doi. 10.3906/sag-2004-168
- By:
- Publication type:
- Article
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19.
- Published in:
- Science Immunology, 2022, v. 7, n. 75, p. 1, doi. 10.1126/sciimmunol.add4906
- By:
- Publication type:
- Article
ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection.
- Published in:
- Science Immunology, 2022, v. 7, n. 74, p. 1, doi. 10.1126/sciimmunol.abo6294
- By:
- Publication type:
- Article
Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib.
- Published in:
- Pharmacia (0428-0296), 2023, v. 70, n. 4, p. 1177, doi. 10.3897/pharmacia.70.e112550
- By:
- Publication type:
- Article
Anomic aphasia after COVID-19 infection: a case report.
- Published in:
- Postepy Psychiatrii i Neurologii / Advances in Psychiatry & Neurology, 2022, v. 31, n. 1, p. 35, doi. 10.5114/ppn.2022.114770
- By:
- Publication type:
- Article
Metformina, diabetul zaharat de tip 2 și COVID-19.
- Published in:
- Farmacist.ro, 2021, n. 4, p. 30
- By:
- Publication type:
- Article
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) DLBCL with CAR T Cell Therapy: A Vodcast and Case Example.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 11, doi. 10.1007/s40487-024-00319-x
- By:
- Publication type:
- Article
Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 233, doi. 10.1007/s40487-024-00274-7
- By:
- Publication type:
- Article
Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 239, doi. 10.1007/s40487-024-00272-9
- By:
- Publication type:
- Article
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 2, p. 263, doi. 10.1007/s40487-023-00228-5
- By:
- Publication type:
- Article
Anti-fibrotic agents could be the game-changer for post-COVID-19 pulmonary fibrosis treatment.
- Published in:
- European Journal of Biological Research, 2022, v. 12, n. 1, p. 1, doi. 10.5281/zenodo.5813126
- By:
- Publication type:
- Article
Pathogenesis of IL-6 and potential therapeutic of IFN-γ in COVID-19.
- Published in:
- European Journal of Biological Research, 2020, v. 10, n. 4, p. 307, doi. 10.5281/zenodo.4004241
- By:
- Publication type:
- Article
Structural biology of SARS-CoV-2 leader protein (nsp1).
- Published in:
- Crystallography Reviews, 2024, v. 30, n. 2, p. 118, doi. 10.1080/0889311X.2024.2325352
- By:
- Publication type:
- Article
Computational Modeling of Two Scenarios of Extreme Development of Biophysical Processes under a Regulated Control Strategy.
- Published in:
- Technical Physics, 2022, v. 67, n. 9, p. 661, doi. 10.1134/S1063784222090055
- By:
- Publication type:
- Article
Clinical experience with tebentafusp in metastatic uveal melanoma.
- Published in:
- Oncolog-Hematolog, 2024, v. 69, n. 4, p. 23
- By:
- Publication type:
- Article
An eye on the news – a case report.
- Published in:
- Oncolog-Hematolog, 2023, n. 64, p. 40
- By:
- Publication type:
- Article
Cytokine release syndrome – diagnosis and management.
- Published in:
- Oncolog-Hematolog, 2023, n. 64, p. 36
- By:
- Publication type:
- Article
Head and neck cancers in the context of SARS-CoV-2 pandemic. Challenges and pitfalls.
- Published in:
- Oncolog-Hematolog, 2021, n. 55, p. 16
- By:
- Publication type:
- Article
Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 2, p. 241, doi. 10.3390/antibiotics11020241
- By:
- Publication type:
- Article
A Closer Look at Dexamethasone and the SARS-CoV-2-Induced Cytokine Storm: In Silico Insights of the First Life-Saving COVID-19 Drug.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 12, p. 1507, doi. 10.3390/antibiotics10121507
- By:
- Publication type:
- Article
Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe Streptococcus suis Infections.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 1, p. 26, doi. 10.3390/antibiotics10010026
- By:
- Publication type:
- Article
CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1721, doi. 10.3390/vaccines11111721
- By:
- Publication type:
- Article
Pustular Eruption following COVID-19 Vaccination: A Narrative Case-Based Review.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1298, doi. 10.3390/vaccines11081298
- By:
- Publication type:
- Article
Modelling of the Innate and Adaptive Immune Response to SARS Viral Infection, Cytokine Storm and Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 127, doi. 10.3390/vaccines11010127
- By:
- Publication type:
- Article
Utility of IL-6 in the Diagnosis, Treatment and Prognosis of COVID-19 Patients: A Longitudinal Study.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1786, doi. 10.3390/vaccines10111786
- By:
- Publication type:
- Article
Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071068
- By:
- Publication type:
- Article
Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040614
- By:
- Publication type:
- Article
Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 192, doi. 10.3390/vaccines10020192
- By:
- Publication type:
- Article